Gene: PLA2G12A
Official Full Name: phospholipase A2 group XIIAprovided by HGNC
Gene Summary: Secreted phospholipase A2 (sPLA2) enzymes liberate arachidonic acid from phospholipids for production of eicosanoids and exert a variety of physiologic and pathologic effects. Group XII sPLA2s, such as PLA2G12A, have relatively low specific activity and are structurally and functionally distinct from other sPLA2s (Gelb et al., 2000 [PubMed 11031251]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08886 | PLA2G12A Knockout cell line (HeLa) | Human | PLA2G12A | 1:3~1:6 | Negative | Online Inquiry |
KO08887 | PLA2G12A Knockout cell line (HCT 116) | Human | PLA2G12A | 1:2~1:4 | Negative | Online Inquiry |
KO08888 | PLA2G12A Knockout cell line (HEK293) | Human | PLA2G12A | 1:3~1:6 | Negative | Online Inquiry |
KO08889 | PLA2G12A Knockout cell line (A549) | Human | PLA2G12A | 1:3~1:4 | Negative | Online Inquiry |
PLA2G12A Gene Knockout Cell Lines are advanced cellular models specifically engineered to facilitate the study of the phospholipase A2 group 12A (PLA2G12A) gene. This product utilizes CRISPR-Cas9 technology to create targeted gene knockouts, leading to the complete loss of PLA2G12A function in various cell types. By removing this gene, researchers can investigate the biological pathways and physiological processes influenced by PLA2G12A without the confounding effects of its activity, thus allowing for a clearer understanding of its role in inflammation, cancer progression, and cellular signaling.
The key functions of the PLA2G12A gene include lipid metabolism and the production of arachidonic acid, which is crucial for the synthesis of bioactive lipids involved in inflammatory responses. By using our knockout cell lines, researchers can observe the downstream effects of PLA2G12A ablation on cellular behavior, such as changes in cell proliferation, migration, and apoptosis. This mechanistic insight provides a valuable platform for elucidating the gene's role in various diseases, making these cell lines a pivotal resource for both basic research and drug development applications.
The scientific importance of these knockout cell lines extends to their vast applications in research settings, including studying neurodegenerative diseases, cardiovascular disorders, and tumor biology. The capability to generate specific mutations at the genetic level empowers scientists to unravel complex disease mechanisms and identify potential therapeutic targets.
What sets our PLA2G12A Gene Knockout Cell Lines apart from alternative models is the precision with which these knockouts are created, alongside robust validation methods to confirm successful gene knockout. Additionally, these cell lines come with comprehensive technical support and detailed documentation that ensure researchers can seamlessly integrate them into their ongoing projects.
For investigators seeking clarity in their experiments and robust models to support their hypotheses, our PLA2G12A Gene Knockout Cell Lines offer unmatched value by streamlining the pathway from hypothesis generation to experimental validation. With decades of expertise in genetic engineering and cellular biology, our company stands as a trusted partner in advancing your research endeavors, equipped with the tools necessary to push the boundaries of scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.